Ataxin 1 Antikörper (AA 350-400)
Kurzübersicht für Ataxin 1 Antikörper (AA 350-400) (ABIN7449649)
Target
Alle Ataxin 1 (ATXN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 350-400
-
Verwendungszweck
- Rabbit anti-Ataxin-1 Antibody, Affinity Purified
-
Aufreinigung
- Affinity Purified
-
Immunogen
- between AA 350 and 400
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IP: 10 μg/mg lysate
WB: Not recommended. Use rabbit anti-Ataxin-1 antibody A302-292A.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- Ataxin 1 (ATXN1)
-
Andere Bezeichnung
- Ataxin-1
-
Hintergrund
- Background: Defects in ataxin-1 are the cause of spinocerebellar ataxia type 1 (SCA1), also known as olivopontocerebellar atrophy I (OPCA I or OPCA1). Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 is caused by expansion of a CAG repeat in the coding region of the ataxin-1 gene. Longer expansions result in earlier onset and more severe clinical manifestations of the disease. Ataxin-1 binds RNA in vitro and may be involved in RNA metabolism [taken from the Universal Protein Resource (UniProt) P54253].
-
Gen-ID
- 6310
-
NCBI Accession
- NP_000323
-
UniProt
- P54253
-
Pathways
- Synaptic Membrane
Target
-